PDA is pleased to announce the results of the 2018 Board of Directors and Officers election.

Executive Committee

The following candidates have been elected to serve as officers on the PDA Board of Directors:

• Chair: Rebecca Devine, PhD, Biopharmaceutical Consultant
• Chair-Elect: Jette Christensen, Scientific Director, Compliance, Novo Nordisk A/S
• Treasurer: Michael Sadowski, Director, Research, Baxter
• Secretary: Steven Lynn, Global Head, Group/Corporate Compliance and Audit, Novartis
• Immediate Past Chair: Martin VanTrieste

PDA also thanks Hal Baseman, COO, ValSource, who ends his term as Immediate Past-Chair.

Directors

PDA congratulates the following new and returning directors to the Board:

• Masahiro Akimoto, Senior Manager, Research and Development and Quality Assurance Division, Otsuka
• Kerry Ingalls, Vice President, Site Operations Amgen
• Mary Oates, Vice President of Innovative Operations and Network Excellence, Pfizer
• Emma Ramnarine, Senior Director Global Biologics, Genentech/Roche

PDA also thanks outgoing directors Ursula Busse, PhD, Head Quality Intelligence and External Relations, Novartis, and Deborah Autor, Senior Vice President, Strategic Global Quality and Regulatory Policy, Mylan for their service on the Board.